Literature DB >> 11727886

The relationship between alcohol use and mortality rates from injuries: a comparison of measures.

R E Mann1, H M Suurvali, R G Smart.   

Abstract

Per capita consumption of alcohol has traditionally been considered to be the leading indicator of population levels of alcohol problems. However, some recent research suggests that this relationship may be weakening, and that drinking pattern measures may be preferable to per capita consumption as problem-level indicators. We compared the ability of per capita alcohol consumption and survey-based measures of alcohol use to predict deaths from injuries in Ontario, Canada, for the period 1977-1996. Per capita consumption and percentage of daily drinkers were significantly related to injury mortality, but percentage of drinkers and percentage of episodic heavy drinkers (those who drank five or more drinks on a drinking occasion) were not. Of the measures we examined, per capita consumption was the strongest indicator of mortality rates from injuries. However, the survey-derived measure of percentage of daily drinkers was similar to per capita consumption in ability to predict problem levels.

Entities:  

Mesh:

Year:  2001        PMID: 11727886     DOI: 10.1081/ada-100107665

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  4 in total

1.  The effect of alcoholic beverage excise tax on alcohol-attributable injury mortalities.

Authors:  Chong Hwan Son; Kudret Topyan
Journal:  Eur J Health Econ       Date:  2010-03-20

2.  A prospective study of risk drinking: at risk for what?

Authors:  Deborah A Dawson; Ting-Kai Li; Bridget F Grant
Journal:  Drug Alcohol Depend       Date:  2008-02-19       Impact factor: 4.492

3.  Ethanol Mediates Cell Cycle Arrest and Apoptosis in SK-N-SH Neuroblastoma Cells.

Authors:  Maria Lee; Byoung-Joon Song; Yongil Kwon
Journal:  J Cancer Prev       Date:  2014-03

4.  Alcohol and other drugs in suicide in Canada: opportunities to support prevention through enhanced monitoring.

Authors:  Heather Orpana; Norman Giesbrecht; Aliya Hajee; Mark S Kaplan
Journal:  Inj Prev       Date:  2020-03-27       Impact factor: 2.399

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.